Nanoparticle depots for controlled and sustained gene delivery.

[1]  Y. Tao,et al.  Fn14 Participates in Neuropathic Pain Through NF-κB Pathway in Primary Sensory Neurons , 2019, Molecular Neurobiology.

[2]  Bin Li,et al.  Nanoscale platforms for messenger RNA delivery. , 2019, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[3]  P. Kantoff,et al.  Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA , 2018, Nature Biomedical Engineering.

[4]  Michel Sadelain,et al.  Gene therapy comes of age , 2018, Science.

[5]  Jonathan Rasmussen,et al.  Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy. , 2017, Nano letters.

[6]  Hao Zhu,et al.  Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA. , 2017, Angewandte Chemie.

[7]  Chao Wang,et al.  Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing. , 2015, Angewandte Chemie.

[8]  Yu Zhang,et al.  siRNA Versus miRNA as Therapeutics for Gene Silencing , 2015, Molecular therapy. Nucleic acids.

[9]  Yuan Wang,et al.  Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo , 2015, ACS nano.

[10]  Daniel G. Anderson,et al.  Non-viral vectors for gene-based therapy , 2014, Nature Reviews Genetics.

[11]  Alfredo Quiñones-Hinojosa,et al.  Biodegradable Polymeric Nanoparticles Show High Efficacy and Specificity at DNA Delivery to Human Glioblastoma in Vitro and in Vivo , 2014, ACS nano.

[12]  Robert Langer,et al.  Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug , 2013, Proceedings of the National Academy of Sciences.

[13]  Chih-Kuang Chen,et al.  Overcoming nonviral gene delivery barriers: perspective and future. , 2013, Molecular pharmaceutics.

[14]  S. Agarwal,et al.  PDMAEMA based gene delivery materials , 2012 .

[15]  N. Zhang,et al.  Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA , 2009, Nanoscale research letters.

[16]  Omid C. Farokhzad,et al.  Nanotechnology for drug delivery: the perfect partnership , 2008, Expert opinion on drug delivery.

[17]  Wim E Hennink,et al.  Biodegradable polymers as non-viral carriers for plasmid DNA delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Robert Langer,et al.  Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. , 2007, Biomaterials.

[19]  G. Prud’homme,et al.  Plasmid-based gene therapy of diabetes mellitus , 2007, Gene Therapy.

[20]  Daniel W. Pack,et al.  Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.

[21]  A. Rolland.  Gene medicines: the end of the beginning? , 2005, Advanced drug delivery reviews.

[22]  H. Lipps,et al.  Towards safe, non-viral therapeutic gene expression in humans , 2005, Nature Reviews Genetics.

[23]  Daniel G. Anderson,et al.  Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters). , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  U. Bakowsky,et al.  Preparation and characterization of cationic PLGA nanospheres as DNA carriers. , 2004, Biomaterials.

[25]  V. Labhasetwar,et al.  Critical Determinants in PLGA/PLA Nanoparticle-Mediated Gene Expression , 2004, Pharmaceutical Research.

[26]  Akin Akinc,et al.  Synthesis of poly (β-amino ester)s optimized for highly effective gene delivery , 2003 .

[27]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[28]  Thomas Kissel,et al.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. , 2003, Biomaterials.

[29]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[30]  A. Fischer,et al.  Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. , 2002, The New England journal of medicine.

[31]  A. Phillips.  The challenge of gene therapy and DNA delivery , 2001, The Journal of pharmacy and pharmacology.

[32]  D. Putnam,et al.  Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Martin L Read,et al.  Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. , 2001, Blood.

[34]  Robert Langer,et al.  Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA , 2000 .

[35]  Manmohan J. Singh,et al.  Cationic microparticles: A potent delivery system for DNA vaccines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Ross,et al.  Polyethylene glycol enhances lipoplex-cell association and lipofection. , 1999, Biochimica et biophysica acta.

[37]  Jeffrey Bonadio,et al.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.

[38]  James M. Wilson,et al.  Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma. , 1998, Human gene therapy.

[39]  Zabner,et al.  Cationic lipids used in gene transfer. , 1997, Advanced drug delivery reviews.

[40]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  H. Paik,et al.  Ionization of Poly(ethylenimine) and Poly(allylamine) at Various pH′s , 1994 .

[42]  E. Nabel,et al.  Gene therapy for vascular smooth muscle cell proliferation after arterial injury. , 1994, Science.

[43]  Murali Ramamoorth,et al.  Non viral vectors in gene therapy- an overview. , 2015, Journal of clinical and diagnostic research : JCDR.

[44]  M. Alonso,et al.  PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery. , 2005, Biomacromolecules.

[45]  G. Kwon,et al.  Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.